Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of €61.25 billion as of November 14, 2025. Its market cap has decreased by -33.22% in one year.

Market Cap

61.25B

Enterprise Value

47.45B

Revenue

12.14B

Ranking

n/a

PE Ratio

15.70

Stock Price

€595.80

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 61.25B, an increase of 46,508.25%. That is a compound annual growth rate of 20.24%.

Market Cap History

Date	Market Cap	% Change
Nov 14, 2025	61.25B	-17.26%
Dec 31, 2024	74.03B	-12.40%
Dec 29, 2023	84.50B	17.20%
Dec 30, 2022	72.10B	24.19%
Dec 31, 2021	58.06B	39.28%
Dec 31, 2020	41.68B	13.96%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Erste Group Bank AG	36.41B
VERBUND AG	23.05B
OMV Aktiengesellschaft	16.01B
Raiffeisen Bank International AG	10.74B
BAWAG Group AG	8.95B
Strabag SE	7.85B
Andritz AG	6.28B
Voestalpine AG	5.96B

Market Cap Rankings